Renewal of Provisional Consent to the Distribution of Medicines

Notice Type: Departmental
Notice Title: Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ketamine
Ketamine hydrochloride 1.153mg/mL equivalent to 1mg/mL ketamine
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 5 May 2017.

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ketamine
Ketamine hydrochloride 4.613mg/mL equivalent to 4mg/mL ketamine
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 5 May 2017.

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ketamine
Ketamine hydrochloride 11.53mg/mL equivalent to 10mg/mL ketamine
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 5 May 2017.

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

RiaSTAP
Fibrinogen 900mg – 1300mg
Powder for injection
CSL Behring (NZ) Limited
CSL Behring GmbH, Marburg, Germany

Note: This renewed consent is valid for two years from 12 May 2017.

Dated this 3rd day of April 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Publication Date: 6 Apr 2017

Tags: Medicines Act Renewal of provisional consent to the distribution of medicines Health

Notice Number: 2017-go1672
Issue Number: 37

Title: View PDF
Description: Principal Edition, 6 April 2017
File Type and Size: PDF (21 KB)
Page Number 0

Tags

Notice Number

Issue Number